Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Physicians, Women | 31 | 2024 | 483 | 10.840 |
Why?
|
Awards and Prizes | 16 | 2023 | 375 | 4.600 |
Why?
|
Medicine | 17 | 2023 | 930 | 4.130 |
Why?
|
Neurology | 10 | 2022 | 762 | 3.450 |
Why?
|
Minority Groups | 12 | 2024 | 1197 | 2.420 |
Why?
|
Leadership | 16 | 2023 | 1349 | 2.340 |
Why?
|
Periodicals as Topic | 10 | 2023 | 1428 | 2.180 |
Why?
|
Societies, Medical | 16 | 2024 | 3739 | 2.160 |
Why?
|
Rehabilitation | 7 | 2021 | 134 | 2.150 |
Why?
|
Gastroenterology | 5 | 2023 | 533 | 1.960 |
Why?
|
Neoplasms | 33 | 2024 | 21507 | 1.700 |
Why?
|
Physical Therapy Modalities | 9 | 2020 | 545 | 1.690 |
Why?
|
Authorship | 4 | 2022 | 268 | 1.690 |
Why?
|
Bibliometrics | 4 | 2020 | 340 | 1.640 |
Why?
|
Publishing | 6 | 2023 | 828 | 1.530 |
Why?
|
Exercise Therapy | 7 | 2024 | 897 | 1.480 |
Why?
|
Preoperative Care | 8 | 2023 | 2238 | 1.450 |
Why?
|
Physicians | 14 | 2024 | 4539 | 1.420 |
Why?
|
Cooking | 5 | 2023 | 313 | 1.270 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2019 | 281 | 1.250 |
Why?
|
Faculty, Medical | 13 | 2023 | 1179 | 1.230 |
Why?
|
Coronavirus Infections | 8 | 2020 | 3143 | 1.210 |
Why?
|
Pneumonia, Viral | 8 | 2020 | 3248 | 1.200 |
Why?
|
Occupational Therapy | 3 | 2020 | 133 | 1.140 |
Why?
|
Cultural Diversity | 5 | 2021 | 357 | 1.130 |
Why?
|
Humans | 208 | 2024 | 739398 | 1.070 |
Why?
|
Advisory Committees | 2 | 2021 | 770 | 1.060 |
Why?
|
Internship and Residency | 10 | 2023 | 5761 | 1.030 |
Why?
|
United States | 58 | 2024 | 69573 | 1.020 |
Why?
|
Pandemics | 11 | 2023 | 8274 | 1.010 |
Why?
|
Sex Factors | 16 | 2022 | 10398 | 0.970 |
Why?
|
Rehabilitation Centers | 8 | 2022 | 254 | 0.970 |
Why?
|
Fellowships and Scholarships | 3 | 2021 | 1058 | 0.950 |
Why?
|
Information Dissemination | 4 | 2020 | 1106 | 0.950 |
Why?
|
Healthcare Disparities | 6 | 2023 | 3138 | 0.940 |
Why?
|
Continuity of Patient Care | 4 | 2017 | 1054 | 0.940 |
Why?
|
Personnel Turnover | 1 | 2024 | 83 | 0.930 |
Why?
|
Mentors | 3 | 2023 | 632 | 0.910 |
Why?
|
Frail Elderly | 3 | 2023 | 690 | 0.910 |
Why?
|
Governing Board | 1 | 2023 | 53 | 0.910 |
Why?
|
Patient Education as Topic | 3 | 2021 | 2275 | 0.900 |
Why?
|
Outpatients | 3 | 2020 | 1469 | 0.890 |
Why?
|
Survivors | 10 | 2017 | 2280 | 0.890 |
Why?
|
Female | 106 | 2024 | 378853 | 0.850 |
Why?
|
Cancer Care Facilities | 3 | 2019 | 401 | 0.810 |
Why?
|
Postpoliomyelitis Syndrome | 4 | 2002 | 11 | 0.810 |
Why?
|
Congresses as Topic | 3 | 2020 | 760 | 0.780 |
Why?
|
Hematology | 1 | 2024 | 217 | 0.770 |
Why?
|
Schools, Medical | 4 | 2021 | 878 | 0.760 |
Why?
|
Speech Therapy | 1 | 2020 | 57 | 0.750 |
Why?
|
Psychiatry | 2 | 2024 | 1686 | 0.750 |
Why?
|
Patient Selection | 3 | 2021 | 4211 | 0.720 |
Why?
|
Women, Working | 1 | 2020 | 87 | 0.710 |
Why?
|
Patient Care Team | 4 | 2016 | 2527 | 0.710 |
Why?
|
Students, Medical | 3 | 2023 | 1850 | 0.700 |
Why?
|
Nobel Prize | 1 | 2019 | 49 | 0.700 |
Why?
|
Cross-Sectional Studies | 22 | 2023 | 24714 | 0.700 |
Why?
|
Health Services Administration | 1 | 2020 | 64 | 0.700 |
Why?
|
Lactation | 1 | 2022 | 410 | 0.690 |
Why?
|
Nutritional Requirements | 1 | 2019 | 283 | 0.620 |
Why?
|
Academic Medical Centers | 5 | 2022 | 2749 | 0.610 |
Why?
|
Salaries and Fringe Benefits | 1 | 2020 | 264 | 0.610 |
Why?
|
Education, Distance | 1 | 2021 | 250 | 0.610 |
Why?
|
Male | 80 | 2024 | 349022 | 0.600 |
Why?
|
Quality of Life | 11 | 2020 | 12640 | 0.600 |
Why?
|
Burnout, Professional | 3 | 2021 | 685 | 0.580 |
Why?
|
Education, Medical, Graduate | 7 | 2023 | 2275 | 0.570 |
Why?
|
Patients | 1 | 2023 | 890 | 0.560 |
Why?
|
Anesthesiology | 3 | 2021 | 1043 | 0.560 |
Why?
|
Consumer Health Information | 1 | 2018 | 209 | 0.540 |
Why?
|
Software Design | 1 | 2016 | 175 | 0.540 |
Why?
|
Academies and Institutes | 4 | 2022 | 316 | 0.520 |
Why?
|
Research | 2 | 2023 | 2001 | 0.510 |
Why?
|
Palliative Care | 4 | 2018 | 3461 | 0.480 |
Why?
|
Information Systems | 1 | 2016 | 410 | 0.470 |
Why?
|
Pediatrics | 2 | 2019 | 3454 | 0.470 |
Why?
|
Income | 2 | 2019 | 1877 | 0.470 |
Why?
|
Clinical Trials as Topic | 5 | 2022 | 7897 | 0.470 |
Why?
|
Education, Medical | 4 | 2020 | 1712 | 0.460 |
Why?
|
Inservice Training | 1 | 2016 | 391 | 0.460 |
Why?
|
Standard of Care | 2 | 2019 | 563 | 0.460 |
Why?
|
Counseling | 2 | 2019 | 1526 | 0.460 |
Why?
|
Biomedical Research | 3 | 2023 | 3301 | 0.450 |
Why?
|
Journal Impact Factor | 3 | 2019 | 155 | 0.450 |
Why?
|
Parental Leave | 2 | 2023 | 77 | 0.440 |
Why?
|
Adaptation, Psychological | 2 | 2021 | 2564 | 0.430 |
Why?
|
Retirement | 1 | 2014 | 212 | 0.430 |
Why?
|
Organizations | 2 | 2023 | 167 | 0.420 |
Why?
|
Vaccines | 1 | 2021 | 802 | 0.420 |
Why?
|
Breast Neoplasms | 5 | 2021 | 20676 | 0.420 |
Why?
|
Orthopedics | 1 | 2021 | 900 | 0.420 |
Why?
|
Editorial Policies | 3 | 2023 | 446 | 0.410 |
Why?
|
Needs Assessment | 4 | 2018 | 1145 | 0.400 |
Why?
|
Telemedicine | 4 | 2022 | 2844 | 0.390 |
Why?
|
Medical Oncology | 3 | 2021 | 2217 | 0.390 |
Why?
|
Orthopedic Procedures | 1 | 2021 | 1286 | 0.390 |
Why?
|
Inpatients | 7 | 2022 | 2478 | 0.380 |
Why?
|
Gender Identity | 3 | 2023 | 674 | 0.380 |
Why?
|
Communicable Diseases | 1 | 2019 | 873 | 0.380 |
Why?
|
Lymphoma, T-Cell | 1 | 2013 | 299 | 0.380 |
Why?
|
Practice Guidelines as Topic | 4 | 2024 | 7274 | 0.380 |
Why?
|
Sex Characteristics | 1 | 2021 | 2583 | 0.370 |
Why?
|
Muscle Weakness | 1 | 2013 | 412 | 0.370 |
Why?
|
Pain | 5 | 2024 | 4923 | 0.370 |
Why?
|
Cross Infection | 1 | 2019 | 1414 | 0.360 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2022 | 2397 | 0.350 |
Why?
|
Health Services Accessibility | 4 | 2023 | 5128 | 0.350 |
Why?
|
Cost Savings | 1 | 2014 | 925 | 0.340 |
Why?
|
Dermatology | 1 | 2019 | 871 | 0.330 |
Why?
|
Patient Care Planning | 2 | 2015 | 918 | 0.330 |
Why?
|
Women | 2 | 2020 | 230 | 0.310 |
Why?
|
Health Status Disparities | 2 | 2022 | 1776 | 0.310 |
Why?
|
Career Mobility | 2 | 2020 | 262 | 0.300 |
Why?
|
Gene Products, env | 3 | 1997 | 263 | 0.300 |
Why?
|
Sex Ratio | 2 | 2018 | 110 | 0.300 |
Why?
|
Career Choice | 3 | 2021 | 742 | 0.290 |
Why?
|
Viral Regulatory and Accessory Proteins | 2 | 1997 | 157 | 0.280 |
Why?
|
Internet | 1 | 2018 | 3048 | 0.280 |
Why?
|
Fatigue | 5 | 2021 | 1524 | 0.270 |
Why?
|
Consensus | 10 | 2023 | 2913 | 0.270 |
Why?
|
Job Satisfaction | 2 | 2021 | 536 | 0.270 |
Why?
|
Recovery of Function | 5 | 2020 | 2924 | 0.270 |
Why?
|
Ambulatory Care | 2 | 2020 | 2711 | 0.270 |
Why?
|
History, 21st Century | 3 | 2019 | 1534 | 0.260 |
Why?
|
Research Design | 1 | 2021 | 5959 | 0.260 |
Why?
|
Exercise | 4 | 2024 | 5591 | 0.260 |
Why?
|
Defective Viruses | 3 | 2001 | 112 | 0.250 |
Why?
|
Aged | 23 | 2023 | 162698 | 0.250 |
Why?
|
Clinical Competence | 1 | 2020 | 4671 | 0.240 |
Why?
|
Spinal Cord Injuries | 2 | 2018 | 932 | 0.240 |
Why?
|
Health Education | 3 | 2020 | 1054 | 0.230 |
Why?
|
History, 20th Century | 3 | 2019 | 2742 | 0.230 |
Why?
|
Polymerase Chain Reaction | 6 | 1997 | 6174 | 0.230 |
Why?
|
Health Services Needs and Demand | 1 | 2011 | 1409 | 0.220 |
Why?
|
Activities of Daily Living | 5 | 2019 | 2410 | 0.220 |
Why?
|
Cost of Illness | 1 | 2013 | 1849 | 0.220 |
Why?
|
Social Identification | 1 | 2023 | 103 | 0.220 |
Why?
|
Primary Dysautonomias | 1 | 2022 | 25 | 0.220 |
Why?
|
Health Personnel | 1 | 2016 | 3203 | 0.220 |
Why?
|
Genetic Vectors | 4 | 2001 | 3419 | 0.210 |
Why?
|
Evidence-Based Medicine | 3 | 2019 | 3606 | 0.210 |
Why?
|
Postoperative Complications | 2 | 2023 | 15194 | 0.200 |
Why?
|
Adult | 27 | 2024 | 213394 | 0.200 |
Why?
|
Fund Raising | 1 | 2021 | 47 | 0.200 |
Why?
|
Poliomyelitis | 1 | 2002 | 104 | 0.200 |
Why?
|
Disability Evaluation | 4 | 2017 | 1824 | 0.200 |
Why?
|
Sindbis Virus | 1 | 2001 | 36 | 0.200 |
Why?
|
Helper Viruses | 1 | 2001 | 58 | 0.200 |
Why?
|
Capsid | 3 | 2001 | 435 | 0.200 |
Why?
|
Meningeal Neoplasms | 2 | 2021 | 1234 | 0.190 |
Why?
|
Family Leave | 1 | 2020 | 18 | 0.190 |
Why?
|
Blood Donors | 1 | 2023 | 357 | 0.190 |
Why?
|
Middle Aged | 25 | 2023 | 212863 | 0.190 |
Why?
|
Moloney murine leukemia virus | 2 | 1997 | 138 | 0.180 |
Why?
|
Attitude of Health Personnel | 3 | 2020 | 3844 | 0.180 |
Why?
|
Interdisciplinary Communication | 2 | 2016 | 952 | 0.180 |
Why?
|
Curriculum | 3 | 2023 | 3575 | 0.180 |
Why?
|
Parents | 2 | 2023 | 3368 | 0.180 |
Why?
|
Compensation and Redress | 1 | 2020 | 71 | 0.180 |
Why?
|
Viral Envelope Proteins | 2 | 2001 | 635 | 0.180 |
Why?
|
Role | 1 | 2020 | 175 | 0.180 |
Why?
|
Policy | 1 | 2023 | 501 | 0.180 |
Why?
|
School Admission Criteria | 1 | 2020 | 104 | 0.180 |
Why?
|
Nootropic Agents | 1 | 2000 | 160 | 0.170 |
Why?
|
Stroke | 2 | 2020 | 9898 | 0.170 |
Why?
|
Psychological Tests | 1 | 2021 | 649 | 0.170 |
Why?
|
Burns | 2 | 2021 | 1808 | 0.170 |
Why?
|
Child | 13 | 2023 | 77033 | 0.160 |
Why?
|
Telecommunications | 1 | 2018 | 80 | 0.160 |
Why?
|
Quarantine | 1 | 2020 | 169 | 0.160 |
Why?
|
Algorithms | 1 | 2019 | 13872 | 0.160 |
Why?
|
Quality of Health Care | 2 | 2013 | 4365 | 0.160 |
Why?
|
Search Engine | 1 | 2019 | 142 | 0.160 |
Why?
|
Semliki forest virus | 1 | 1997 | 12 | 0.160 |
Why?
|
Patient Satisfaction | 2 | 2020 | 3382 | 0.160 |
Why?
|
Motivation | 3 | 2023 | 1965 | 0.160 |
Why?
|
Analgesics, Opioid | 2 | 2019 | 3650 | 0.150 |
Why?
|
Insurance, Disability | 1 | 2017 | 26 | 0.150 |
Why?
|
Sexual Harassment | 1 | 2018 | 77 | 0.150 |
Why?
|
Gastrointestinal Tract | 1 | 2023 | 814 | 0.150 |
Why?
|
United States Department of Veterans Affairs | 1 | 2021 | 873 | 0.150 |
Why?
|
Leupeptins | 1 | 1997 | 122 | 0.150 |
Why?
|
Nerve Compression Syndromes | 1 | 1998 | 160 | 0.150 |
Why?
|
Accreditation | 1 | 2020 | 448 | 0.150 |
Why?
|
Leukemia Virus, Murine | 1 | 1997 | 116 | 0.150 |
Why?
|
Workplace | 1 | 2023 | 837 | 0.150 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2020 | 335 | 0.150 |
Why?
|
Cumulative Trauma Disorders | 1 | 1998 | 146 | 0.150 |
Why?
|
Subacute Care | 1 | 2019 | 168 | 0.150 |
Why?
|
DNA | 4 | 1997 | 7275 | 0.140 |
Why?
|
Prejudice | 1 | 2021 | 572 | 0.140 |
Why?
|
Retroviridae Infections | 1 | 1997 | 150 | 0.140 |
Why?
|
Leukemia, Experimental | 1 | 1997 | 247 | 0.140 |
Why?
|
Survival Rate | 3 | 2017 | 12761 | 0.140 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1997 | 191 | 0.140 |
Why?
|
Radiology, Interventional | 1 | 2020 | 460 | 0.140 |
Why?
|
Home Care Services | 2 | 2020 | 602 | 0.140 |
Why?
|
Premenopause | 1 | 2000 | 1028 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2023 | 1296 | 0.140 |
Why?
|
Tendinopathy | 1 | 1998 | 145 | 0.140 |
Why?
|
Employment | 2 | 2020 | 1119 | 0.140 |
Why?
|
Publications | 1 | 2018 | 194 | 0.130 |
Why?
|
Patient-Centered Care | 2 | 2017 | 1435 | 0.130 |
Why?
|
Menopause | 1 | 2023 | 1613 | 0.130 |
Why?
|
Retroviridae | 2 | 1996 | 913 | 0.130 |
Why?
|
Acetylcysteine | 1 | 1997 | 273 | 0.130 |
Why?
|
Hand Injuries | 1 | 1998 | 242 | 0.130 |
Why?
|
Research Support as Topic | 1 | 2020 | 706 | 0.130 |
Why?
|
Risk Assessment | 6 | 2020 | 23294 | 0.130 |
Why?
|
DNA Primers | 2 | 1997 | 2893 | 0.130 |
Why?
|
Neuromuscular Diseases | 1 | 2018 | 256 | 0.130 |
Why?
|
Disease Progression | 8 | 2023 | 13237 | 0.130 |
Why?
|
Accidental Falls | 2 | 2002 | 1055 | 0.130 |
Why?
|
Surgical Procedures, Operative | 1 | 2007 | 1867 | 0.130 |
Why?
|
Sciatic Nerve | 1 | 1998 | 611 | 0.130 |
Why?
|
Postoperative Period | 1 | 2020 | 1835 | 0.130 |
Why?
|
Confidentiality | 2 | 2016 | 610 | 0.130 |
Why?
|
Qualitative Research | 1 | 2023 | 2656 | 0.130 |
Why?
|
Caregivers | 2 | 2017 | 2067 | 0.130 |
Why?
|
Wounds and Injuries | 2 | 2010 | 2394 | 0.130 |
Why?
|
Perception | 1 | 2021 | 1177 | 0.120 |
Why?
|
Mental Disorders | 2 | 2014 | 6570 | 0.120 |
Why?
|
Brain Injuries | 2 | 1998 | 2021 | 0.120 |
Why?
|
Socioeconomic Factors | 4 | 2021 | 7726 | 0.120 |
Why?
|
Specialization | 1 | 2019 | 776 | 0.120 |
Why?
|
Sex Distribution | 1 | 2019 | 2296 | 0.120 |
Why?
|
Resilience, Psychological | 1 | 2021 | 650 | 0.120 |
Why?
|
Tumor Virus Infections | 1 | 1997 | 452 | 0.120 |
Why?
|
Computer Security | 1 | 2016 | 264 | 0.120 |
Why?
|
Self-Help Devices | 2 | 2006 | 67 | 0.120 |
Why?
|
Receptors, Virus | 1 | 1997 | 648 | 0.120 |
Why?
|
Boston | 3 | 2020 | 9314 | 0.120 |
Why?
|
Delivery of Health Care | 3 | 2022 | 5272 | 0.120 |
Why?
|
Program Development | 1 | 2020 | 1313 | 0.120 |
Why?
|
Memory Disorders | 1 | 2000 | 1183 | 0.110 |
Why?
|
Aging | 2 | 2023 | 8613 | 0.110 |
Why?
|
Work Capacity Evaluation | 1 | 2013 | 46 | 0.110 |
Why?
|
HIV-1 | 6 | 1997 | 6931 | 0.110 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1993 | 248 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 629 | 0.110 |
Why?
|
Nurse's Role | 1 | 2014 | 209 | 0.110 |
Why?
|
HIV Envelope Protein gp41 | 1 | 1994 | 315 | 0.110 |
Why?
|
Infection Control | 1 | 2020 | 968 | 0.110 |
Why?
|
Virus Replication | 1 | 2001 | 2529 | 0.110 |
Why?
|
Treatment Outcome | 10 | 2021 | 62693 | 0.110 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 1990 | 769 | 0.110 |
Why?
|
Disabled Persons | 2 | 2021 | 1207 | 0.110 |
Why?
|
Social Support | 1 | 2021 | 2112 | 0.100 |
Why?
|
Mood Disorders | 1 | 1998 | 1102 | 0.100 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1990 | 794 | 0.100 |
Why?
|
Safety Management | 2 | 2017 | 782 | 0.100 |
Why?
|
Anesthetics, Local | 1 | 1998 | 987 | 0.100 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 941 | 0.100 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1407 | 0.100 |
Why?
|
Dystonia | 1 | 1994 | 361 | 0.100 |
Why?
|
DNA, Recombinant | 2 | 1990 | 475 | 0.090 |
Why?
|
Sodium | 1 | 1996 | 1625 | 0.090 |
Why?
|
HLA-DR Antigens | 2 | 1989 | 643 | 0.090 |
Why?
|
Retrospective Studies | 12 | 2022 | 76631 | 0.090 |
Why?
|
Health Care Costs | 2 | 2014 | 3226 | 0.090 |
Why?
|
Ethics, Medical | 1 | 1995 | 793 | 0.090 |
Why?
|
Thrombocytopenia | 1 | 2018 | 1170 | 0.090 |
Why?
|
Occupational Diseases | 1 | 1998 | 1474 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1621 | 0.090 |
Why?
|
Patient Transfer | 1 | 2017 | 763 | 0.090 |
Why?
|
Mental Health | 1 | 2023 | 2946 | 0.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2020 | 1607 | 0.090 |
Why?
|
Mobility Limitation | 1 | 2013 | 403 | 0.090 |
Why?
|
Genetic Linkage | 2 | 1997 | 2433 | 0.080 |
Why?
|
Genetic Diseases, Inborn | 2 | 1994 | 588 | 0.080 |
Why?
|
Down-Regulation | 1 | 1996 | 2999 | 0.080 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57650 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1503 | 0.080 |
Why?
|
Patient Discharge | 2 | 2019 | 3286 | 0.080 |
Why?
|
Age Factors | 3 | 2021 | 18349 | 0.080 |
Why?
|
Health Policy | 2 | 2018 | 2655 | 0.080 |
Why?
|
Anecdotes as Topic | 1 | 2008 | 57 | 0.080 |
Why?
|
Combined Modality Therapy | 4 | 2017 | 8605 | 0.080 |
Why?
|
Teaching | 1 | 1995 | 1166 | 0.080 |
Why?
|
Time Factors | 3 | 2019 | 40050 | 0.080 |
Why?
|
Critical Illness | 1 | 2020 | 2656 | 0.080 |
Why?
|
Survival Analysis | 2 | 2017 | 10247 | 0.080 |
Why?
|
Prognosis | 4 | 2021 | 28901 | 0.070 |
Why?
|
Anxiety Disorders | 1 | 1998 | 2674 | 0.070 |
Why?
|
Human Immunodeficiency Virus Proteins | 2 | 1997 | 65 | 0.070 |
Why?
|
Demography | 2 | 2022 | 1650 | 0.070 |
Why?
|
Adolescent | 5 | 2022 | 85405 | 0.070 |
Why?
|
Genes, Dominant | 1 | 1989 | 883 | 0.070 |
Why?
|
Health Promotion | 1 | 2018 | 2187 | 0.070 |
Why?
|
Dementia | 1 | 2000 | 2488 | 0.070 |
Why?
|
Membrane Glycoproteins | 1 | 1997 | 3768 | 0.070 |
Why?
|
Public Health | 1 | 2019 | 2587 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2018 | 1800 | 0.070 |
Why?
|
Polymorphism, Genetic | 2 | 1994 | 4332 | 0.070 |
Why?
|
Young Adult | 4 | 2022 | 56255 | 0.070 |
Why?
|
Carrier Proteins | 2 | 1997 | 5012 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3441 | 0.070 |
Why?
|
Major Histocompatibility Complex | 1 | 1989 | 935 | 0.070 |
Why?
|
Membrane Proteins | 3 | 1997 | 7862 | 0.070 |
Why?
|
HeLa Cells | 3 | 1997 | 3119 | 0.070 |
Why?
|
Communication | 1 | 2019 | 3722 | 0.070 |
Why?
|
Lower Extremity | 1 | 2013 | 1145 | 0.070 |
Why?
|
Indicators and Reagents | 2 | 1997 | 460 | 0.060 |
Why?
|
Immunity, Innate | 1 | 1997 | 2950 | 0.060 |
Why?
|
Glioblastoma | 1 | 2020 | 3431 | 0.060 |
Why?
|
Crohn Disease | 1 | 1997 | 2299 | 0.060 |
Why?
|
Canada | 2 | 2020 | 2021 | 0.060 |
Why?
|
Therapy, Computer-Assisted | 1 | 2006 | 274 | 0.060 |
Why?
|
Goals | 2 | 2023 | 702 | 0.060 |
Why?
|
Molecular Sequence Data | 7 | 1997 | 18125 | 0.060 |
Why?
|
Pregnancy | 3 | 2023 | 29002 | 0.060 |
Why?
|
Self Efficacy | 2 | 2018 | 607 | 0.060 |
Why?
|
Patient Readmission | 1 | 2018 | 3106 | 0.060 |
Why?
|
Quality Improvement | 1 | 2018 | 3730 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 1998 | 4920 | 0.060 |
Why?
|
Base Sequence | 6 | 1997 | 12804 | 0.060 |
Why?
|
Mass Screening | 1 | 2019 | 5265 | 0.060 |
Why?
|
Length of Stay | 3 | 2021 | 6295 | 0.050 |
Why?
|
Antigens, Surface | 1 | 1987 | 1667 | 0.050 |
Why?
|
Kidney | 2 | 1996 | 7144 | 0.050 |
Why?
|
Calcium | 1 | 1996 | 5742 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 5213 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 38942 | 0.050 |
Why?
|
Substance-Related Disorders | 1 | 1998 | 4239 | 0.050 |
Why?
|
Braces | 1 | 2002 | 135 | 0.050 |
Why?
|
Cell Line | 5 | 2001 | 15987 | 0.050 |
Why?
|
Tacrine | 1 | 2000 | 5 | 0.050 |
Why?
|
Specialty Boards | 1 | 2022 | 227 | 0.050 |
Why?
|
Oligonucleotide Probes | 3 | 1997 | 425 | 0.050 |
Why?
|
Diet | 1 | 2018 | 7876 | 0.050 |
Why?
|
State Medicine | 1 | 2022 | 219 | 0.050 |
Why?
|
Professional-Family Relations | 1 | 2004 | 481 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2021 | 303 | 0.050 |
Why?
|
Indans | 1 | 2000 | 96 | 0.050 |
Why?
|
Tissue Plasminogen Activator | 1 | 2006 | 1263 | 0.050 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2020 | 183 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2021 | 8791 | 0.040 |
Why?
|
Genes, Viral | 2 | 1991 | 719 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2000 | 2277 | 0.040 |
Why?
|
Nutritional Status | 2 | 2018 | 1587 | 0.040 |
Why?
|
Models, Genetic | 1 | 1989 | 3493 | 0.040 |
Why?
|
Cholinesterase Inhibitors | 1 | 2000 | 239 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12643 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2017 | 5147 | 0.040 |
Why?
|
Computer Terminals | 1 | 1998 | 44 | 0.040 |
Why?
|
Betamethasone | 1 | 1998 | 45 | 0.040 |
Why?
|
New York City | 1 | 2020 | 704 | 0.040 |
Why?
|
Parenting | 1 | 2004 | 672 | 0.040 |
Why?
|
Probability | 2 | 1997 | 2500 | 0.040 |
Why?
|
Ileitis | 1 | 1997 | 44 | 0.040 |
Why?
|
Sciatica | 1 | 1998 | 98 | 0.040 |
Why?
|
Conflict of Interest | 1 | 2023 | 541 | 0.040 |
Why?
|
Splints | 1 | 1998 | 111 | 0.040 |
Why?
|
Luminescent Proteins | 1 | 2001 | 853 | 0.040 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 1997 | 76 | 0.040 |
Why?
|
Severity of Illness Index | 2 | 2006 | 15511 | 0.040 |
Why?
|
Polyomavirus | 1 | 1978 | 248 | 0.040 |
Why?
|
Analgesics | 1 | 2004 | 1034 | 0.040 |
Why?
|
Muscles | 1 | 2002 | 1608 | 0.040 |
Why?
|
Trauma Severity Indices | 1 | 2019 | 480 | 0.040 |
Why?
|
Brefeldin A | 1 | 1997 | 72 | 0.040 |
Why?
|
DNA, Viral | 3 | 1994 | 2223 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 1997 | 13816 | 0.040 |
Why?
|
Haploidy | 1 | 1997 | 136 | 0.040 |
Why?
|
Nervous System | 1 | 2000 | 557 | 0.040 |
Why?
|
Templates, Genetic | 1 | 1997 | 211 | 0.040 |
Why?
|
Giant Cells | 1 | 1997 | 187 | 0.040 |
Why?
|
Cell Transformation, Viral | 1 | 1978 | 565 | 0.040 |
Why?
|
RNA, Viral | 3 | 1997 | 2907 | 0.040 |
Why?
|
Chondroitin Sulfates | 1 | 1997 | 185 | 0.040 |
Why?
|
Virus Assembly | 1 | 1997 | 145 | 0.040 |
Why?
|
Cyclopentanes | 1 | 1997 | 95 | 0.040 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 1997 | 97 | 0.040 |
Why?
|
Heart Diseases | 1 | 2010 | 2782 | 0.040 |
Why?
|
Factor V | 1 | 1997 | 174 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2000 | 578 | 0.040 |
Why?
|
Emotions | 1 | 2008 | 2642 | 0.030 |
Why?
|
Capacity Building | 1 | 2018 | 246 | 0.030 |
Why?
|
Animals | 15 | 2023 | 168368 | 0.030 |
Why?
|
Life Style | 2 | 2018 | 3817 | 0.030 |
Why?
|
Sodium-Calcium Exchanger | 1 | 1996 | 91 | 0.030 |
Why?
|
Infarction | 1 | 1997 | 242 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 1997 | 230 | 0.030 |
Why?
|
Jews | 1 | 1997 | 385 | 0.030 |
Why?
|
Genomic Imprinting | 1 | 1997 | 331 | 0.030 |
Why?
|
3T3 Cells | 1 | 1997 | 1103 | 0.030 |
Why?
|
British Columbia | 1 | 1995 | 237 | 0.030 |
Why?
|
Internal Medicine | 1 | 2002 | 996 | 0.030 |
Why?
|
Virion | 1 | 1997 | 435 | 0.030 |
Why?
|
Skilled Nursing Facilities | 1 | 2019 | 368 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2019 | 3514 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2092 | 0.030 |
Why?
|
Restriction Mapping | 3 | 1991 | 879 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 12948 | 0.030 |
Why?
|
Golgi Apparatus | 1 | 1996 | 410 | 0.030 |
Why?
|
Signal Transduction | 2 | 2000 | 23355 | 0.030 |
Why?
|
Electromyography | 1 | 2000 | 1389 | 0.030 |
Why?
|
CHO Cells | 1 | 1997 | 1404 | 0.030 |
Why?
|
Pain Measurement | 1 | 2004 | 3419 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 11699 | 0.030 |
Why?
|
Professional Autonomy | 1 | 1995 | 177 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 1996 | 12049 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1997 | 561 | 0.030 |
Why?
|
Antigens, Viral | 1 | 1978 | 1033 | 0.030 |
Why?
|
Medicare | 2 | 2023 | 6497 | 0.030 |
Why?
|
Gene Expression | 3 | 1997 | 7788 | 0.030 |
Why?
|
Incidence | 2 | 2017 | 20913 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 1997 | 727 | 0.030 |
Why?
|
Avian myeloblastosis virus | 1 | 1993 | 22 | 0.030 |
Why?
|
Friend murine leukemia virus | 1 | 1993 | 65 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7128 | 0.030 |
Why?
|
Estrogen Replacement Therapy | 1 | 2000 | 1203 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 9812 | 0.030 |
Why?
|
Cricetinae | 1 | 1997 | 2468 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 1997 | 877 | 0.030 |
Why?
|
Nucleic Acid Conformation | 2 | 1994 | 913 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 1997 | 687 | 0.030 |
Why?
|
Patient Advocacy | 1 | 1995 | 353 | 0.030 |
Why?
|
Physician's Role | 1 | 2020 | 943 | 0.030 |
Why?
|
Protein Precursors | 1 | 1997 | 1154 | 0.030 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1997 | 947 | 0.030 |
Why?
|
Osteoporosis | 1 | 2002 | 1576 | 0.030 |
Why?
|
Mice | 10 | 2000 | 81002 | 0.030 |
Why?
|
Immunoglobulin Constant Regions | 1 | 1992 | 59 | 0.030 |
Why?
|
HIV Reverse Transcriptase | 1 | 1993 | 215 | 0.030 |
Why?
|
Antioxidants | 1 | 2000 | 1659 | 0.030 |
Why?
|
Piperidines | 1 | 2000 | 1597 | 0.030 |
Why?
|
Escherichia coli Infections | 1 | 1996 | 529 | 0.030 |
Why?
|
Health Care Rationing | 1 | 1995 | 439 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2000 | 2440 | 0.030 |
Why?
|
Basal Ganglia | 1 | 1994 | 547 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 1992 | 291 | 0.020 |
Why?
|
Regression Analysis | 1 | 2021 | 6452 | 0.020 |
Why?
|
Terminology as Topic | 1 | 1998 | 1548 | 0.020 |
Why?
|
DNA, Complementary | 1 | 1994 | 2049 | 0.020 |
Why?
|
Organ Specificity | 1 | 1996 | 2004 | 0.020 |
Why?
|
Immunoglobulin Variable Region | 1 | 1992 | 423 | 0.020 |
Why?
|
Intestine, Small | 1 | 1997 | 1242 | 0.020 |
Why?
|
Gastrins | 1 | 1990 | 81 | 0.020 |
Why?
|
B-Lymphocyte Subsets | 1 | 1992 | 246 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 1997 | 1820 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2023 | 3180 | 0.020 |
Why?
|
Hepatovirus | 1 | 1990 | 50 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 1997 | 1331 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 1978 | 1977 | 0.020 |
Why?
|
Nephritis, Interstitial | 1 | 1991 | 149 | 0.020 |
Why?
|
Transfection | 2 | 1996 | 5884 | 0.020 |
Why?
|
Proviruses | 1 | 1991 | 316 | 0.020 |
Why?
|
Gene Products, tat | 1 | 1990 | 120 | 0.020 |
Why?
|
Low Back Pain | 1 | 1998 | 948 | 0.020 |
Why?
|
Hospitalization | 2 | 2020 | 10208 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 1997 | 2704 | 0.020 |
Why?
|
Colitis | 1 | 1997 | 1146 | 0.020 |
Why?
|
Poliovirus | 1 | 1990 | 109 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 2688 | 0.020 |
Why?
|
Actins | 1 | 1997 | 2112 | 0.020 |
Why?
|
Chronic Disease | 1 | 2004 | 9133 | 0.020 |
Why?
|
HIV-2 | 1 | 1990 | 171 | 0.020 |
Why?
|
Shock, Septic | 1 | 1996 | 764 | 0.020 |
Why?
|
Gene Transfer Techniques | 1 | 1994 | 1227 | 0.020 |
Why?
|
Hybridization, Genetic | 1 | 1989 | 112 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 1995 | 1008 | 0.020 |
Why?
|
Informed Consent | 1 | 1995 | 988 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 1997 | 4743 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 1997 | 1925 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1997 | 2241 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 1998 | 1777 | 0.020 |
Why?
|
Blotting, Southern | 1 | 1989 | 803 | 0.020 |
Why?
|
Educational Measurement | 1 | 1995 | 1205 | 0.020 |
Why?
|
Chimera | 1 | 1990 | 488 | 0.020 |
Why?
|
Thiamine Pyrophosphate | 1 | 1987 | 8 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1978 | 2936 | 0.020 |
Why?
|
Thalamus | 1 | 1994 | 1020 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 1990 | 351 | 0.020 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 1991 | 358 | 0.020 |
Why?
|
Genome, Viral | 1 | 1991 | 668 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53037 | 0.020 |
Why?
|
Databases, Factual | 1 | 2023 | 7690 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 1990 | 326 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8669 | 0.020 |
Why?
|
Histocompatibility Testing | 1 | 1989 | 741 | 0.020 |
Why?
|
Program Evaluation | 1 | 1995 | 2484 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 1997 | 2901 | 0.020 |
Why?
|
Tubulin | 1 | 1990 | 696 | 0.020 |
Why?
|
Microinjections | 1 | 1987 | 326 | 0.020 |
Why?
|
Capsid Proteins | 1 | 1990 | 479 | 0.020 |
Why?
|
Alleles | 3 | 2000 | 6942 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1987 | 723 | 0.020 |
Why?
|
Patient Participation | 1 | 1995 | 1441 | 0.020 |
Why?
|
Lymph Nodes | 1 | 1997 | 3454 | 0.020 |
Why?
|
X Chromosome | 1 | 1989 | 815 | 0.020 |
Why?
|
Artifacts | 1 | 1994 | 1905 | 0.020 |
Why?
|
Haplotypes | 2 | 1989 | 2782 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2000 | 5830 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1997 | 4374 | 0.020 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1989 | 1470 | 0.020 |
Why?
|
Genome, Human | 1 | 1997 | 4419 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6686 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 1990 | 1783 | 0.010 |
Why?
|
Thrombosis | 1 | 1997 | 2961 | 0.010 |
Why?
|
Genetic Markers | 1 | 1989 | 2630 | 0.010 |
Why?
|
Pedigree | 1 | 1990 | 4640 | 0.010 |
Why?
|
Gene Frequency | 1 | 1989 | 3585 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 3908 | 0.010 |
Why?
|
Child, Preschool | 1 | 2004 | 40802 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9122 | 0.010 |
Why?
|
Proteins | 1 | 1997 | 6082 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 1997 | 14740 | 0.010 |
Why?
|
Risk Factors | 2 | 2019 | 71974 | 0.010 |
Why?
|
Decision Making | 1 | 1995 | 3854 | 0.010 |
Why?
|
Antigens, CD | 1 | 1992 | 4024 | 0.010 |
Why?
|
Wheelchairs | 1 | 2001 | 77 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 1987 | 1698 | 0.010 |
Why?
|
Brain | 2 | 2022 | 26345 | 0.010 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1992 | 1592 | 0.010 |
Why?
|
Rats | 2 | 1996 | 24270 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 1997 | 5721 | 0.010 |
Why?
|
Primary Health Care | 1 | 2017 | 4537 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 1992 | 4522 | 0.010 |
Why?
|
Mutation | 4 | 1997 | 29658 | 0.010 |
Why?
|
Trans-Activators | 1 | 1990 | 2922 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 11410 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1997 | 10142 | 0.010 |
Why?
|
Intestinal Absorption | 1 | 1981 | 420 | 0.010 |
Why?
|
Prosencephalon | 1 | 2000 | 304 | 0.010 |
Why?
|
Neural Tube Defects | 1 | 2000 | 253 | 0.010 |
Why?
|
Eye Abnormalities | 1 | 2000 | 240 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 1997 | 17384 | 0.010 |
Why?
|
HIV Envelope Protein gp160 | 1 | 1997 | 99 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 1996 | 21863 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1978 | 547 | 0.010 |
Why?
|
Neurons | 1 | 1997 | 9336 | 0.010 |
Why?
|
Reticulin | 1 | 1997 | 21 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2000 | 3615 | 0.010 |
Why?
|
Hemodynamics | 1 | 1987 | 4197 | 0.010 |
Why?
|
GTPase-Activating Proteins | 1 | 2000 | 498 | 0.010 |
Why?
|
Mesenteric Veins | 1 | 1997 | 89 | 0.010 |
Why?
|
Synaptophysin | 1 | 1997 | 141 | 0.010 |
Why?
|
Self Tolerance | 1 | 1997 | 124 | 0.010 |
Why?
|
Mesenteric Arteries | 1 | 1997 | 183 | 0.010 |
Why?
|
Pia Mater | 1 | 1997 | 88 | 0.010 |
Why?
|
Morphogenesis | 1 | 2000 | 759 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2000 | 1934 | 0.010 |
Why?
|
Microscopy, Electron | 2 | 1991 | 2665 | 0.010 |
Why?
|
Basement Membrane | 1 | 1997 | 356 | 0.010 |
Why?
|
Molecular Weight | 1 | 1978 | 2257 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 1997 | 9259 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2000 | 1223 | 0.010 |
Why?
|
Cross Reactions | 1 | 1997 | 840 | 0.010 |
Why?
|
Laminin | 1 | 1997 | 418 | 0.010 |
Why?
|
Personality Disorders | 1 | 1980 | 708 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1997 | 956 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1997 | 2517 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13635 | 0.010 |
Why?
|
Child Behavior Disorders | 1 | 1980 | 805 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15070 | 0.010 |
Why?
|
Models, Statistical | 1 | 1989 | 5113 | 0.010 |
Why?
|
Multigene Family | 1 | 1997 | 1107 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 40389 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1997 | 805 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2000 | 3137 | 0.010 |
Why?
|
Proteoglycans | 1 | 1997 | 835 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1978 | 1402 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1997 | 1883 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2000 | 14558 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2000 | 19220 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 1 | 1988 | 3689 | 0.010 |
Why?
|
Equipment Design | 1 | 2001 | 3583 | 0.010 |
Why?
|
Immunoglobulin Joining Region | 1 | 1992 | 36 | 0.010 |
Why?
|
Homozygote | 1 | 1997 | 1788 | 0.010 |
Why?
|
Gene Targeting | 1 | 1996 | 886 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 1997 | 9734 | 0.010 |
Why?
|
Cytokines | 2 | 1997 | 7298 | 0.010 |
Why?
|
Neuroglia | 1 | 1997 | 928 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1992 | 1088 | 0.010 |
Why?
|
Medical Illustration | 1 | 1991 | 134 | 0.010 |
Why?
|
Heterozygote | 1 | 1997 | 2798 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 1997 | 1662 | 0.010 |
Why?
|
tat Gene Products, Human Immunodeficiency Virus | 1 | 1990 | 126 | 0.010 |
Why?
|
Fibroblasts | 1 | 2000 | 4137 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1991 | 1583 | 0.010 |
Why?
|
Antibodies | 1 | 1997 | 2450 | 0.010 |
Why?
|
Kidney Function Tests | 1 | 1991 | 681 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2000 | 3007 | 0.010 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1992 | 658 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1996 | 2208 | 0.010 |
Why?
|
Vitamin D | 1 | 1981 | 3197 | 0.000 |
Why?
|
Lymphocyte Activation | 1 | 1997 | 5522 | 0.000 |
Why?
|
Monocytes | 1 | 1996 | 2583 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 1987 | 11668 | 0.000 |
Why?
|
Mitochondria, Heart | 1 | 1987 | 248 | 0.000 |
Why?
|
Peptides | 1 | 1997 | 4395 | 0.000 |
Why?
|
Plasmids | 1 | 1990 | 2307 | 0.000 |
Why?
|
Viral Proteins | 1 | 1991 | 1900 | 0.000 |
Why?
|
Exons | 1 | 1990 | 2430 | 0.000 |
Why?
|
DNA-Binding Proteins | 1 | 2000 | 9622 | 0.000 |
Why?
|
Dogs | 1 | 1987 | 3915 | 0.000 |
Why?
|
Amino Acids | 1 | 1988 | 1727 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1990 | 2131 | 0.000 |
Why?
|
Sterols | 1 | 1981 | 62 | 0.000 |
Why?
|
Lymph | 1 | 1981 | 80 | 0.000 |
Why?
|
Portal Vein | 1 | 1981 | 433 | 0.000 |
Why?
|
Tissue Distribution | 1 | 1981 | 2345 | 0.000 |
Why?
|
Transcription, Genetic | 1 | 1990 | 7709 | 0.000 |
Why?
|
Electrocardiography | 1 | 1987 | 6426 | 0.000 |
Why?
|